Latest news

Bioservo has completed a directed issue of approximately SEK 14 million (regulatory information)

Bioservo is investigating the prerequisites for carrying out a directed share issue (regulatory information)

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

Financial calendar

02 Apr, 2020 Annual Report
07 May, 2020 Quarter 1, 2020 + Annual General Meeting
18 Aug, 2020 Quarter 2, 2020
05 Nov, 2020 Quarter 3, 2020
23 Feb, 2021 Year-End